Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection

BACKGROUND: COVID-19 pandemic has spread worldwide since December 2019. Serological tests for SARS-CoV-2 antibody testing are needed for detection of current or past infections. A wide range of commercial tests is available. However, most of them need to be validated. STUDY DESIGN: The aim was to co...

Descripción completa

Detalles Bibliográficos
Autores principales: Serrano, Maria Martínez, Rodríguez, David Navalpotro, Palop, Nuria Tormo, Arenas, Roberto Olmos, Córdoba, Marta Moreno, Mochón, Mª Dolores Ocete, Cardona, Concepción Gimeno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323682/
https://www.ncbi.nlm.nih.gov/pubmed/32659710
http://dx.doi.org/10.1016/j.jcv.2020.104529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323682/
https://www.ncbi.nlm.nih.gov/pubmed/32659710
http://dx.doi.org/10.1016/j.jcv.2020.104529

Ejemplares similares